Indeed, MSCs are known to enhance tumour angiogenesis in response to hypoxic signalling, in a process analogous to wound-healing [51], and EphA3 is up-regulated by hypoxia, including during neo-angiogenesis [23,52]. This evidence concerns the gene EPHA3 and neoplasm.